Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 13.95
-0.21 (-1.48%)
Aug 28, 2026, 4:00 PM EST
Cipher Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cipher Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $19.95. The average 1-year stock price forecast is 43.01% higher than the current stock price, while the lowest is $17.00 (+21.86%) and the highest is $22.00 (+57.71%).
Price Target: $19.95 (+43.01%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cipher Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $22.00 → $20.00 | Buy | Maintains | $22.00 → $20.00 | +43.37% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
52.04M
from 50.45M
Increased by 3.15%
Revenue Next Year
60.72M
from 52.04M
Increased by 16.68%
EPS This Year
n/a
EPS Next Year
n/a